Citable company snapshot
Bristol Myers Squibb's latest SEC-sourced 2026-06-30 period shows $12.97B in revenue and $3.32B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jun 30, 2026 | $12.97B | $11.49B | +12.9% |
| Gross Profit | Dec 31, 2020 | $8.16B | $8.04B | +1.5% |
| Operating Income | Mar 31, 2012 | $1.40B | $1.29B | +8.9% |
| Net Income | Jun 30, 2026 | $3.32B | $2.68B | +23.9% |
| Operating Cash Flow (computed) | Jun 30, 2026 | $3.39B | $1.10B | +207.3% |
| Free Cash Flow (computed) | Jun 30, 2026 | $3.09B | $757.00M | +307.9% |
Source: SEC EDGAR financial statements; period Jun 30, 2026; filed Jul 30, 2026; accession 0000014272-26-000020.
BMY company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.